EAPCI Column

DOI:

EAPCI focus on the Online Educational Initiatives

EAPCI Online Educational Initiatives include the EAPCI Journal Club and EAPCI webinars. The goal of these online initiatives is to provide high-quality educational content for EAPCI members. 

The EAPCI Journal Club commenced during the 2022-2024 term and has continued with great success into the 2024-2026 term. Although the credo of the EAPCI Journal Club is #bythefellowsforthefellows, there are significant educational benefits for all members of the interventional cardiology community. The Journal Club sessions follow a standard process, in which a high-impact paper is presented by an EAPCI fellow, followed by insights and critical appraisal from a senior author of the paper or a recognised expert in the topic. EAPCI members may put forward burning questions surrounding the trial prior to the Journal Club session using the EAPCI presidential X account, and three questions which are deemed of highest value to the community are addressed by the expert during the presentation. Ongoing interaction from the audience is warmly welcomed during each Journal Club session, with questions moderated by a dedicated chat moderator acting as the voice of the interventional community in putting these questions to the expert in the room.

So far in 2025, there have been two EAPCI Journal Club sessions. The season kicked off with OCCUPI, with Thomas Johnson and Erik Rafflenbeul acting as moderator and chat moderator, respectively, and Pawel Gąsior presenting the key findings of the trial.  The session was greatly enhanced by the presence of Sung-Jin Hong, the first author of the trial, who provided his perspective, highlighting the differences between the OCCUPI trial and ILUMIEN IV as well as providing interesting insights into the use of intracoronary imaging in both East Asian and non-East Asian countries.

The second Journal Club session of 2025 took place in June, with the RHEIA trial discussed. The moderators were EAPCI President Alaide Chieffo and chat moderator Erik Rafflenbeul. Giulia Botti presented the results of the trial from the fellows’ perspective, and Hélène Eltchaninoff, the senior author, provided her valuable insights into this important study. Once again, the session was very interactive, with interesting and beneficial questions asked by the EAPCI community, leading to a very educational discussion amongst the hosts and expert.

EAPCI webinars allow a more in-depth dive into a particular topic relevant to the EAPCI community. During the “Interventional therapy for resistant hypertension: state of the art in 2025 and future perspectives” webinar, Emanuele Barbato, EAPCI Past-President, hosted Felix Mahfoud and Isabella Sudano. There was an extensive discussion and review of the current indications for renal denervation, appraisal of the contemporary trial data for the management of resistant and uncontrolled hypertension, along with a practical discussion on how to set up a successful renal denervation pathway.

Finally, a two-part webinar series focused on the management of obese patients with and without diabetes in acute coronary syndromes. Part one, hosted by EAPCI President Alaide Chieffo, focused on inpatient care, with a case presentation by Valeria Paradies and a review of the evidence from Mamas Mamas.  Finally, Konstantinos Koskinas from the European Association of Preventive Cardiology discussed the importance of a multidisciplinary approach for these patients, focusing on the importance of pharmacological therapy, including prioritising the use of antidiabetic medications with improving cardiovascular benefit and, finally, considering bariatric procedures in certain highly selected patients.

In the second of this webinar series, Thomas Luescher hosted, Jorge Sanz Sanchez presented a case, and Massimo Federico, a diabetologist, provided significant insights into the management of cardiovascular disease in patients with diabetes. Finally, Giulio Stefanini provided his insight into inflammation in acute coronary syndrome, the clinical impacts, and how this can be managed, touching on the use of GLP1-RA. 

The webinar series has been well received by the community and is available to watch on ESC 365 (esc365.escardio.org) for any members who may have missed out on the live transmissions. 

Volume 21 Number 14
Jul 21, 2025
Volume 21 Number 14
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00601 Jun 15, 2026
Unloading the clock: when timing meets physiology in STEMI shock
Møller J and Schrage B
free

Editorial

10.4244/EIJ-D-26-00394 Jun 15, 2026
Transcatheter edge-to-edge repair for primary mitral regurgitation: what lies ahead?
Petronio A and Mazzola M
free

Original Research

10.4244/EIJ-D-25-01308 Jun 15, 2026
Temporal trends in mitral edge-to-edge repair for primary mitral regurgitation
Koell B et al

Flashlight

10.4244/EIJ-D-25-01353 Jun 15, 2026
Transcatheter approximation of papillary muscles
Tekieli L et al
open access

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved